TY - JOUR
T1 - Reported barriers to evaluation in chronic care
T2 - experiences in six European countries
AU - Knai, Cécile
AU - Nolte, Ellen
AU - Brunn, Matthias
AU - Elissen, Arianne
AU - Conklin, Annalijn
AU - Pedersen, Janice Pedersen
AU - Brereton, Laura
AU - Erler, Antje
AU - Frølich, Anne
AU - Flamm, Maria
AU - Fullerton, Birgitte
AU - Jacobsen, Ramune
AU - Krohn, Robert
AU - Saz-Parkinson, Zuleika
AU - Vrijhoef, Bert
AU - Chevreul, Karine
AU - Durand-Zaleski, Isabelle
AU - Farsi, Fadila
AU - Sarría-Santamera, Antonio
AU - Soennichsen, Andreas
N1 - Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
PY - 2013/5
Y1 - 2013/5
N2 - Introduction: The growing movement of innovative approaches to chronic disease management in Europe has not been matched by a corresponding effort to evaluate them. This paper discusses challenges to evaluation of chronic disease management as reported by experts in six European countries. Methods: We conducted 42 semi-structured interviews with key informants from Austria, Denmark, France, Germany, The Netherlands and Spain involved in decision-making and implementation of chronic disease management approaches. Interviews were complemented by a survey on approaches to chronic disease management in each country. Finally two project teams (France and the Netherlands) conducted in-depth case studies on various aspects of chronic care evaluation. Results: We identified three common challenges to evaluation of chronic disease management approaches: (1) a lack of evaluation culture and related shortage of capacity; (2) reluctance of payers or providers to engage in evaluation and (3) practical challenges around data and the heterogeity of IT infrastructure. The ability to evaluate chronic disease management interventions is influenced by contextual and cultural factors. Conclusions: This study contributes to our understanding of some of the most common underlying barriers to chronic care evaluation by highlighting the views and experiences of stakeholders and experts in six European countries. Overcoming the cultural, political and structural barriers to evaluation should be driven by payers and providers, for example by building in incentives such as feedback on performance, aligning financial incentives with programme objectives, collectively participating in designing an appropriate framework for evaluation, and making data use and accessibility consistent with data protection policies.
AB - Introduction: The growing movement of innovative approaches to chronic disease management in Europe has not been matched by a corresponding effort to evaluate them. This paper discusses challenges to evaluation of chronic disease management as reported by experts in six European countries. Methods: We conducted 42 semi-structured interviews with key informants from Austria, Denmark, France, Germany, The Netherlands and Spain involved in decision-making and implementation of chronic disease management approaches. Interviews were complemented by a survey on approaches to chronic disease management in each country. Finally two project teams (France and the Netherlands) conducted in-depth case studies on various aspects of chronic care evaluation. Results: We identified three common challenges to evaluation of chronic disease management approaches: (1) a lack of evaluation culture and related shortage of capacity; (2) reluctance of payers or providers to engage in evaluation and (3) practical challenges around data and the heterogeity of IT infrastructure. The ability to evaluate chronic disease management interventions is influenced by contextual and cultural factors. Conclusions: This study contributes to our understanding of some of the most common underlying barriers to chronic care evaluation by highlighting the views and experiences of stakeholders and experts in six European countries. Overcoming the cultural, political and structural barriers to evaluation should be driven by payers and providers, for example by building in incentives such as feedback on performance, aligning financial incentives with programme objectives, collectively participating in designing an appropriate framework for evaluation, and making data use and accessibility consistent with data protection policies.
U2 - 10.1016/j.healthpol.2013.01.019
DO - 10.1016/j.healthpol.2013.01.019
M3 - Journal article
C2 - 23453595
SN - 0168-8510
VL - 110
SP - 220
EP - 228
JO - Health Policy
JF - Health Policy
IS - 2-3
ER -